Literature DB >> 31701766

Sinomenine hydrochloride exerts antitumor outcome in ovarian cancer cells by inhibition of long non-coding RNA HOST2 expression.

Yuting Xu1, Tao Jiang1, Changhe Wang1, Fei Wang1.   

Abstract

Background: Accumulating evidence displays that sinomenine hydrochloride (SH) are utilised to treat a variety of cancers. Nevertheless, the influences of SH on ovarian cancer stay blurry. We endeavoured to uncover the antitumor effects of SH on ovarian cancer and underlying mechanism(s).
Methods: Human ovarian epithelial cell line (HOEpiC), Caov3 and SKOV3 cells were administrated with SH and/or transfection with pc-long non-coding RNA (lncRNA) human ovarian cancer-specific transcript 2 (HOST2), then cell viability, cell cycle and apoptosis and the related-proteins were respectively inspected by MTT, flow cytometry, and Western blot. In addition, expression of HOST2 was investigated by real-time PCR. Kaplan-Meier manner with the log-rank investigation was achieved to calculate overall survival.
Results: SH remarkably repressed cell viability, evoked apoptosis and induced cell cycle arrest in G0/G1. Moreover, SH statistically decreased HOST2 expression in Caov3 and SKOV3 cells. Overexpression of HOST2 significantly reversed the effects of SH on Caov3 cell viability, cell cycle and apoptosis. Clinical findings confirmed that HOST2 was profoundly higher expressed in ovarian cancer tissues and cells, and HOST2 predicated unfavourable prognosis of ovarian cancer individuals.
Conclusion: Our findings recommended that SH exerted the antitumor effect in ovarian cancer cells by hindering expression of HOST2.

Entities:  

Keywords:  HOST2; Ovarian cancer; apoptosis; cell viability; sinomenine hydrochloride

Mesh:

Substances:

Year:  2019        PMID: 31701766     DOI: 10.1080/21691401.2019.1687496

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  5 in total

Review 1.  The Challenges and Opportunities of LncRNAs in Ovarian Cancer Research and Clinical Use.

Authors:  Martín Salamini-Montemurri; Mónica Lamas-Maceiras; Aida Barreiro-Alonso; Ángel Vizoso-Vázquez; Esther Rodríguez-Belmonte; María Quindós-Varela; María Esperanza Cerdán
Journal:  Cancers (Basel)       Date:  2020-04-21       Impact factor: 6.639

2.  Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Suppression of Mitosis by Down-Regulating the Expression and the Activity of CDK1.

Authors:  Xiaoyan Qu; Bing Yu; Mengmei Zhu; Xiaomei Li; Lishan Ma; Chuyin Liu; Yixing Zhang; Zhongping Cheng
Journal:  Onco Targets Ther       Date:  2021-02-05       Impact factor: 4.147

3.  Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression.

Authors:  Haili Xu; Jiayan Dong; Junhui Hou; Rui Gao
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-01       Impact factor: 2.629

4.  Inferring Latent Disease-lncRNA Associations by Label-Propagation Algorithm and Random Projection on a Heterogeneous Network.

Authors:  Min Chen; Yingwei Deng; Ang Li; Yan Tan
Journal:  Front Genet       Date:  2022-02-04       Impact factor: 4.599

5.  The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review.

Authors:  Zilong Wu; Zihao Xu; Boyao Yu; Jingtao Zhang; Bentong Yu
Journal:  Biomed Res Int       Date:  2020-08-15       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.